Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110476

Characterization of Opiate-mediated Responses of the Feline Ileum and Ileocecal Sphincter

Ann Ouyang, Carole J. Clain, William J. Snape Jr., and Sidney Cohen

Gastrointestinal Section, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104

Find articles by Ouyang, A. in: PubMed | Google Scholar

Gastrointestinal Section, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104

Find articles by Clain, C. in: PubMed | Google Scholar

Gastrointestinal Section, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104

Find articles by Snape, W. in: PubMed | Google Scholar

Gastrointestinal Section, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104

Find articles by Cohen, S. in: PubMed | Google Scholar

Published March 1, 1982 - More info

Published in Volume 69, Issue 3 on March 1, 1982
J Clin Invest. 1982;69(3):507–515. https://doi.org/10.1172/JCI110476.
© 1982 The American Society for Clinical Investigation
Published March 1, 1982 - Version history
View PDF
Abstract

Although opioid peptides have been demonstrated immunohistochemically in the feline intestine, the action of these peptides is unknown. The aims of this study were: (a) to determine the distal ileal and ileocecal sphincter (ICS) responses to morphine sulfate (MS), methionine enkephalin (ME) and leucine enkephalin (LE); (b) to determine the mechanism by which exogenous opiates mediate these responses; (c) to determine the type of receptor involved in mediating these responses and (d) to ascertain whether endogenous opiate-mediated responses may be vagally induced. The ICS responded to all three opiate agonists with tonic and phasic contractions, the latter being associated with increased spike activity. The EDmax for ICS pressure response was 1 μg/kg for ME, 5 μg/kg for LE, and 150 μg/kg for MS. The distal ileum responded with increased spike activity and phasic contractions. The EDmax for the ileal motility index response was 1.0 × 10−1 μg/kg for ME, 1 μg/kg for LE, and 150 μg/kg for MS. Thus, both sites demonstrated similar dose-response relationships, both responding to at least 100 times lower doses of enkephalins than MS. The ICS contraction preceded ileal contractions. The ileal and ICS response was not antagonized by atropine, hexamethonium, phentolamine, propranolol, cinanserin, or tetrodotoxin. Naloxone, 600 μg/kg, antagonized the response to the enkephalins while 10 μg/kg antagonized the response to MS. Higher doses of the specific-receptor agonist SKF 10047 and κ-receptor agonist ketocyclazocine were required before a contractile response was elicited. Electrical stimulation of the cervical vagus induced ICS contraction and a fall in blood pressure. The ICS contractile response but not the blood pressure response was inhibited by naloxone 1 mg/kg. These data indicate: (a) tonic and phasic ICS contraction followed by ileal contraction may be mediated through δ-type opiate receptors located in the muscle membrane and (b) opiate-mediated ICS contraction may be induced during vagal stimulation.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 507
page 507
icon of scanned page 508
page 508
icon of scanned page 509
page 509
icon of scanned page 510
page 510
icon of scanned page 511
page 511
icon of scanned page 512
page 512
icon of scanned page 513
page 513
icon of scanned page 514
page 514
icon of scanned page 515
page 515
Version history
  • Version 1 (March 1, 1982): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts